Article Information
PubMed
Print ISSN
Online ISSN
History
- Received January 31, 2019
- Accepted March 18, 2019
- Published online August 23, 2019.
Article Versions
- Earlier version (April 1, 2019 - 09:24).
- Earlier version (April 2, 2019 - 06:27).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Stephen C. Lenhard1,
- Allen McAlexander1,
- Anthony Virtue1,
- William Fieles,
- Tina Skedzielewski,
- Mary Rambo,
- Han Trinh,
- Shih-Hsun Cheng,
- Hyundae Hong,
- Albert Isidro-Llobet,
- Alan Nadin,
- Robert Geske,
- Jean-Louis Klein,
- Dennis Lee,
- Beat M. Jucker, and
- Erding Hu
- Bioimaging (S.C.L., T.S., M.R., S.-H.C., H.H., B.M.J.), Renal Discovery Group, Future Pipeline Discovery (A.V, E.H.), Experimental Cell and Tissue Biology, Target and Pathway Validation (W.F., H.T., R.G., J.-L.K.), Drug Delivery (A.M., D.L.), and Drug Design and Selection (A.I.-L., A.N.), GlaxoSmithKline plc, Collegeville, Pennsylvania
- Address correspondence to:
Erding Hu, GlaxoSmithKline plc (GSK), Mail Stop: UP1W-1210, 1250 South Collegeville Road, Collegeville, PA 19426. E-mail: Erding.Hu{at}gsk.com